SEARCH

SEARCH BY CITATION

References

  • 1
    Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY & Chen WT (2010) Correlation of NF–kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma. BMC Cancer 10, 437.
  • 2
    Mehanna H, Paleri V, West CM & Nutting C (2010) Head and neck cancer –part 1: epidemiology, presentation, and prevention. BMJ 341, c4684.
  • 3
    Lacko M, Oude Ophuis MB, Peters WH & Manni JJ (2009) Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. Anticancer Res 29, 753761.
  • 4
    Nieminen MT, Uittamo J, Salaspuro M & Rautemaa R (2009) Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol 45, e245248.
  • 5
    Salaspuro M (2009) Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers. Scand J Gastroenterol 44, 912925.
  • 6
    Langevin F, Crossan GP, Rosado IV, Arends MJ & Patel KJ (2011) Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 475, 5358.
  • 7
    Lyakhovich A & Surralles J (2007) New roads to FA/BRCA pathway: H2AX. Cell Cycle 6, 10191023.
  • 8
    Basu A & Krishnamurthy S (2010) Cellular responses to cisplatin-induced DNA damage. J Nucleic Acids 2010, 116. doi:10.4061/2010/201367.
  • 9
    Budas GR, Disatnik MH, Chen CH & Mochly-Rosen D (2010) Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J Mol Cell Cardiol 48, 757764.
  • 10
    Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Ueyama Y, Yamashita H & Hinoda Y (2006) ALDH2 1510 G/A (Glu487Lys) polymorphism interaction with age in head and neck squamous cell carcinoma. Tumour Biol 27, 334338.
  • 11
    Druesne-Pecollo N, Tehard B, Mallet Y, Gerber M, Norat T, Hercberg S & Latino-Martel P (2009) Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 10, 173180.
  • 12
    Xu C, Li CY & Kong AN (2005) Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28, 249268.
  • 13
    Soya SS, Vinod T, Reddy KS, Gopalakrishnan S & Adithan C (2007) Genetic polymorphisms of glutathione-S–transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population. Eur J Cancer 43, 26982706.
  • 14
    Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV & Ward LS (2004) GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Lett 209, 129137.
  • 15
    Nowak SJ, Pai CY & Corces VG (2003) Protein phosphatase 2A activity affects histone H3 phosphorylation and transcription in Drosophila melanogaster. Mol Cell Biol 23, 61296138.
  • 16
    Seo SB, McNamara P, Heo S, Turner A, Lane WS & Chakravarti D (2001) Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104, 119130.
  • 17
    Carlson SG, Eng E, Kim EG, Perlman EJ, Copeland TD & Ballermann BJ (1998) Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor. J Am Soc Nephrol 9, 18731880.
  • 18
    Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD & Gutkind JS (2008) Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 14, 10021014.
  • 19
    Leopoldino AM, Squarize CH, Garcia CB, Almeida LO, Pestana CR, Polizello AC, Uyemura SA, Tajara EH, Gutkind JS & Curti C (2012) Accumulation of the SET protein in HEK293T cells and mild oxidative stress: cell survival or death signaling. Mol Cell Biochem 363, 6574.
  • 20
    Leopoldino AM, Squarize CH, Garcia CB, Almeida LO, Pestana CR, Sobral LM, Uyemura SA, Tajara EH, Gutkind JS & Curti C (2012) SET protein accumulates in HNSCC and contributes to cell survival: antioxidant defense, Akt phosphorylation and AVOs acidification. Oral Oncol 48, 11061113.
  • 21
    Perego P, Zuco V, Gatti L & Zunino F (2012) Sensitization of tumor cells by targeting histone deacetylases. Biochem Pharmacol 83, 987994.
  • 22
    Young SC, Wang CJ, Hsu JD, Hsu JL & Chou FP (2006) Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract. Arch Toxicol 80, 319327.
  • 23
    Cadoni G, Boccia S, Petrelli L, Di Giannantonio P, Arzani D, Giorgio A, De Feo E, Pandolfini M, Galli P, Paludetti G, et al. (2012) A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta Otorhinolaryngol Ital 32, 111.
  • 24
    Brunner AH, Hinterholzer S, Riss P, Heinze G, Weiss K & Brustmann H (2011) Expression of gamma-H2AX in endometrial carcinomas: an immunohistochemical study with p53. Gynecol Oncol 121, 206211.
  • 25
    Muenyi CS, Pinhas AR, Fan TW, Brock GN, Helm CW & States JC (2012) Sodium arsenite +/- hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses. Toxicol Sci 127, 139149.
  • 26
    Waldman T, Kinzler KW & Vogelstein B (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55, 51875190.
  • 27
    Canela N, Rodriguez-Vilarrupla A, Estanyol JM, Diaz C, Pujol MJ, Agell N & Bachs O (2003) The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity. J Biol Chem 278, 11581164.
  • 28
    Karetsou Z, Emmanouilidou A, Sanidas I, Liokatis S, Nikolakaki E, Politou AS & Papamarcaki T (2009) Identification of distinct SET/TAF-Ibeta domains required for core histone binding and quantitative characterisation of the interaction. BMC Biochem 10, 10.
  • 29
    Zevallos JP, Hanasono MM, Li G, Wei Q & Sturgis EM (2010) Glutathione-S-transferase polymorphisms and complications of microvascular head and neck reconstruction. Arch Facial Plast Surg 12, 373378.
  • 30
    Cervoni N, Detich N, Seo SB, Chakravarti D & Szyf M (2002) The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J Biol Chem 277, 2502625031.
  • 31
    ten Klooster JP, Leeuwen I, Scheres N, Anthony EC & Hordijk PL (2007) Rac1-induced cell migration requires membrane recruitment of the nuclear oncogene SET. EMBO J 26, 336345.
  • 32
    Kim DW, Kim KB, Kim JY, Lee KS & Seo SB (2010) Negative regulation of neuronal cell differentiation by INHAT subunit SET/TAF-Ibeta. Biochem Biophys Res Commun 400, 419425.
  • 33
    Huang G, Mills L & Worth LL (2007) Expression of human glutathione S–transferase P1 mediates the chemosensitivity of osteosarcoma cells. Mol Cancer Ther 6, 16101619.
  • 34
    Abaji C, Cousineau I & Belmaaza A (2005) BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis. Cancer Res 65, 41174125.
  • 35
    Yeudall WA, Crawford RY, Ensley JF & Robbins KC (1994) MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 15, 26832686.
  • 36
    Kang JK, Kim SW, Jeong HG, Park JK, Park Y & Lee JS (1999) Isolation and characterization of a mutant defective in the production of methanol dehydrogenase from a new restricted facultative methanol-oxidizing bacterium. IUBMB Life 48, 209213.
  • 37
    Kim YD, Eom SY, Ogawa M, Oyama T, Isse T, Kang JW, Zhang YW, Kawamoto T & Kim H (2007) Ethanol-induced oxidative DNA damage and CYP2E1 expression in liver tissue of Aldh2 knockout mice. J Occup Health 49, 363369.
  • 38
    Livak KJ & Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402408.